Close Menu

USPTO

NEW YORK (GenomeWeb) – Following the release of the US Patent and Trademark Office's guidelines on how its examiners should interpret the US Supreme Court's decision in Association for Molecular Pathology et al. v.

Title: MADS Gene Regulatory Sequences for Expressing Gene Products in Plant Reproductive Tissue
Patent Number: 8,679,844

Title: Determinants of Sensitivity to Chemotherapeutic Agents
Patent Number: 8,673,869
Filed: Dec. 14, 2005

A US federal district court in Utah denied Myriad Genetics and other plaintiffs a preliminary junction that would have stopped Ambry Genetics from selling competing BRCA tests, even though the court determined this may harm Myriad's business.

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection
Patent Number: 8,664,188
Filed: Dec. 11, 2009

Title: Drug Carrier and Drug Carrier Kit for Inhibiting Fibrosis
Patent Number: 8,652,526
Filed: April 4, 2012

NEW YORK (GenomeWeb News) – Genetic Technologies announced today it received a further ex parte re-examination certificate from the US Patent and Trademark Office for certain claims related to the company's non-coding DNA patent.

Title: Prevention of Chlamydia Infection using siRNA
Patent Number: 8,648,052
Filed: Oct. 8, 2007

Title: Lipid-containing Formulations
Patent Number: 8,642,076
Filed: Aug. 16, 2011

Title: Apoptotic Cell-mediated Transfection of Mammalian Cells with Interfering RNA
Patent Number: 8,637,476

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.